Reference SummaryBrayton CF, Vet Pathol 2012 Jan;49(1):85-105
Title |
Pathobiology of aging mice and GEM: background strains and experimental design. | ||||||||||
Authors |
Brayton CF; Treuting PM; Ward JM | ||||||||||
Journal |
Vet Pathol | ||||||||||
Volume |
49 | ||||||||||
Issue |
1 | ||||||||||
Year |
2012 | ||||||||||
Pages |
85-105 | ||||||||||
Abstract |
The use of induced and spontaneous mutant mice and genetically engineered mice (and combinations thereof) to study cancers and other aging phenotypes to advance improved functional human life spans will involve studies of aging mice. Genetic background contributes to pathology phenotypes and to causes of death as well as to longevity. Increased recognition of expected phenotypes, experimental variables that influence phenotypes and research outcomes, and experimental design options and rationales can maximize the utility of genetically engineered mice (GEM) models to translational research on aging. This review aims to provide resources to enhance the design and practice of chronic and longevity studies involving GEM. C57BL6, 129, and FVB/N strains are emphasized because of their widespread use in the generation of knockout, transgenic, and conditional mutant GEM. Resources are included also for pathology of other inbred strain families, including A, AKR, BALB/c, C3H, C57L, C58, CBA, DBA, GR, NOD.scid, SAMP, and SJL/J, and non-inbred mice, including 4WC, AB6F1, Ames dwarf, B6, 129, B6C3F1, BALB/c,129, Het3, nude, SENCAR, and several Swiss stocks. Experimental strategies for long-term cross-sectional and longitudinal studies to assess causes of or contributors to death, disease burden, spectrum of pathology phenotypes, longevity, and functional healthy life spans (health spans) are compared and discussed. | ||||||||||
Links |
J:235854 – MGI References 22215684 – National Library of Medicine/PubMed |
||||||||||
Strain Notes
|
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
(C57BL/6 x C3H)F1 | Adrenal gland - Cortex lesion | Adrenal gland - Cortex |
observed |
||
BALB/cAnNBdf | Adrenal gland - Cortex tumor | Adrenal gland - Cortex |
observed |
||
FVB/NTac | Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla |
observed |
||
BALB/cStCrlfC3Hf/Nctr | Adrenal gland - Subcapsular cell hyperplasia - spindle cell | Adrenal gland - Subcapsular cell |
observed |
||
(BALB/cByJ x C57BL/6J)F1 x (C3H/HeJ x DBA/2J)F1 | Adrenal gland hyperplasia | Adrenal gland |
observed |
||
NMRI | Adrenal gland tumor | Adrenal gland |
observed |
||
BALB/cStCrlfC3Hf/Nctr | Blood tumor | Blood |
observed |
||
C57BL/6JfC3Hf/Nctr | Blood tumor | Blood |
observed |
||
[(AKR/J x DBA/2J)F1] x [(C57BL/6J x SJL/J)F1] | Blood tumor | Blood |
43 - 55 |
||
B6;129 | Blood tumor | Blood |
observed |
||
B6;129 | Blood vessel hemangioma | Blood vessel |
observed |
||
C;129P2 | Blood vessel hemangioma | Blood vessel |
observed |
||
C57BL/6 | Blood vessel hemangiosarcoma | Blood vessel |
observed |
||
B6;129 | Blood vessel hemangiosarcoma | Blood vessel |
observed |
||
(BALB/cByJ x C57BL/6J)F1 x (C3H/HeJ x DBA/2J)F1 | Blood vessel hemangiosarcoma | Blood vessel |
observed |
||
C57BL/6JNia | Blood vessel neoplasm | Blood vessel |
0 - 8 |
||
C57BL/6J | Blood vessel neoplasm | Blood vessel |
2 - 4 |
||
B6;129S4 | Blood vessel neoplasm | Blood vessel |
0 - 10 |
||
B6;129 | Blood vessel neoplasm | Blood vessel |
9 |
||
129S4/SvJae | Blood vessel neoplasm | Blood vessel |
0 - 12.9 |
||
C57BL/6JNia | Bone neoplasm | Bone |
0 - 2 |
||
C57BL/6J | Bone neoplasm | Bone |
0 - 2 |
||
B6;129S4 | Bone neoplasm | Bone |
0 |
||
129S4/SvJae | Bone neoplasm | Bone |
0 |
||
BALB/cStCrlfC3Hf/Nctr | Eye - Harderian gland adenoma | Eye - Harderian gland |
observed |
||
FVB/NTac | Eye - Harderian gland adenoma - acidophilic | Eye - Harderian gland |
observed |
||
C57BL/6JNia | Eye - Harderian gland neoplasm | Eye - Harderian gland |
0 |
||
C57BL/6J | Eye - Harderian gland neoplasm | Eye - Harderian gland |
0 |
||
B6;129S4 | Eye - Harderian gland neoplasm | Eye - Harderian gland |
0 - 4 |
||
B6;129 | Eye - Harderian gland neoplasm | Eye - Harderian gland |
0 |
||
129S4/SvJae | Eye - Harderian gland neoplasm | Eye - Harderian gland |
0 - 53.9 |
||
129S4/SvJae | Eye - Harderian gland tumor | Eye - Harderian gland |
observed |
||
BALB/cAnNBdf | Eye - Harderian gland tumor | Eye - Harderian gland |
observed |
||
NMRI | Eye - Harderian gland tumor | Eye - Harderian gland |
observed |
||
C57BL/6JNia | Intestine neoplasm | Intestine |
0 - 4 |
||
C57BL/6J | Intestine neoplasm | Intestine |
0 - 4 |
||
B6;129S4 | Intestine neoplasm | Intestine |
4 |
||
129S4/SvJae | Intestine neoplasm | Intestine |
2.3 - 2.6 |
||
SENCAR | Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell lymphoma | Leukocyte - Lymphocyte - B-lymphocyte - Follicular center cell |
observed |
||
C57L | Leukocyte - Lymphocyte - B-lymphocyte lymphoma | Leukocyte - Lymphocyte - B-lymphocyte |
observed |
||
SJL/J | Leukocyte - Lymphocyte - B-lymphocyte lymphoma | Leukocyte - Lymphocyte - B-lymphocyte |
observed |
||
CFW | Leukocyte - Lymphocyte - B-lymphocyte lymphoma | Leukocyte - Lymphocyte - B-lymphocyte |
observed |
||
SAMP | Leukocyte - Lymphocyte - B-lymphocyte lymphoma - immunoblastic | Leukocyte - Lymphocyte - B-lymphocyte |
observed |
||
SJL/J | Leukocyte - Lymphocyte - Pre-B-lymphocyte lymphoma | Leukocyte - Lymphocyte - Pre-B-lymphocyte |
observed |
||
NOD.CB17-Prkdcscid/J | Leukocyte - Lymphocyte - Pro-T-lymphocyte lymphoma | Leukocyte - Lymphocyte - Pro-T-lymphocyte |
observed |
||
AKR/J | Leukocyte - Lymphocyte - T-lymphocyte lymphoma | Leukocyte - Lymphocyte - T-lymphocyte |
observed |
||
C58/J | Leukocyte - Lymphocyte - T-lymphocyte lymphoma | Leukocyte - Lymphocyte - T-lymphocyte |
observed |
||
C.B-17-Prkdcscid | Leukocyte - Lymphocyte - T-lymphocyte lymphoma | Thymus |
observed |
||
SJL/J | Leukocyte - Lymphocyte lymphoma - Hodgkin | Leukocyte - Lymphocyte |
observed |
||
CD-1 | Leukocyte - Lymphocyte lymphoma - lymphocytic | Leukocyte - Lymphocyte |
observed |
||
C57BL/6JNia | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
observed - 15.4 |
||
C57BL/6J | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
observed - 15 |
||
B6;129S4 | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
6 |
||
129S4/SvJae | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
0 - 4.2 |
||
C57BL/6NNia | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
observed |
||
FVB/NTac | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
observed |
||
FVB/NHsd | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
observed |
||
SAMP | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
observed |
||
SENCAR | Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Leukocyte - Monocyte - Macrophage - Histiocyte |
observed |
||
AKR/J | Leukocyte leukemia | Leukocyte |
observed |
||
C58 | Leukocyte leukemia | Leukocyte |
observed |
||
C58/J | Leukocyte leukemia | Leukocyte |
observed |
||
SJL/J | Leukocyte leukemia | Leukocyte |
observed |
||
[not specified]-Foxn1nu | Leukocyte leukemia | Leukocyte |
observed |
||
C57BL/6JNia | Leukocyte lymphoma | Leukocyte |
observed - 50 |
||
C57BL/6J | Leukocyte lymphoma | Leukocyte |
observed - 57 |
||
B6;129S4 | Leukocyte lymphoma | Leukocyte |
observed - 67 |
||
129S4/SvJae | Leukocyte lymphoma | Leukocyte |
2.5 - 6.3 |
||
AKR | Leukocyte lymphoma | Leukocyte |
observed |
||
BALB/cStCrlfC3Hf/Nctr | Leukocyte lymphoma | Leukocyte |
observed |
||
C57BL/6N | Leukocyte lymphoma | Leukocyte |
observed |
||
C57BL/6NNia | Leukocyte lymphoma | Leukocyte |
observed |
||
FVB/NTac | Leukocyte lymphoma | Leukocyte |
observed |
||
NOD/ShiLt | Leukocyte lymphoma | Leukocyte |
observed |
||
NOD.129S-Rag2tm1Fwa | Leukocyte lymphoma | Leukocyte |
observed |
||
[(AKR/J x DBA/2J)F1] x [(C57BL/6J x SJL/J)F1] | Leukocyte lymphoma | Leukocyte |
observed |
||
(Af x C57BL/6)F1 | Leukocyte lymphoma | Leukocyte |
observed |
||
(C57BL/6 x C3H/HeN)F1 | Leukocyte lymphoma | Leukocyte |
observed |
||
(C57BL/6 x C3H)F1 | Leukocyte lymphoma |
|
Leukocyte |
observed |
|
(C57BL/6 x C3H)F1 | Leukocyte lymphoma | Leukocyte |
observed |
||
C;129P2 | Leukocyte lymphoma | Leukocyte |
observed |
||
(BALB/cByJ x C57BL/6J)F1 x (C3H/HeJ x DBA/2J)F1 | Leukocyte lymphoma | Leukocyte |
observed |
||
[not specified]-Foxn1nu | Leukocyte lymphoma | Leukocyte |
observed |
||
CD-1 | Leukocyte lymphoma | Leukocyte |
observed |
||
C58 | Leukocyte lymphoma - lymphosarcoma | Leukocyte |
observed |
||
CD-1 | Leukocyte lymphoma - pleomorphic | Leukocyte |
observed |
||
BALB/cStCrlfC3Hf/Nctr | Liver - Hepatocyte neoplasm | Liver - Hepatocyte |
observed |
||
FVB/NTac | Liver - Hepatocyte tumor | Liver - Hepatocyte |
observed |
||
(C57BL/6 x C3H/HeN)F1 | Liver adenoma | Liver |
observed |
||
(C57BL/6 x C3H)F1 | Liver adenoma | Liver |
observed |
||
(C57BL/6 x C3H/HeN)F1 | Liver carcinoma | Liver |
observed |
||
(C57BL/6 x C3H)F1 | Liver carcinoma | Liver |
observed |
||
B6;129S4 | Liver hepatocellular adenoma | Liver |
observed |
||
SENCAR | Liver hepatocellular adenoma | Liver |
observed |
||
CD-1 | Liver hepatocellular adenoma | Liver |
observed |
||
B6;129 | Liver hepatocellular carcinoma | Liver |
observed |
||
B6;129S4 | Liver hepatocellular carcinoma | Liver |
observed |
||
C;129P2 | Liver hepatocellular carcinoma | Liver |
observed |
||
CD-1 | Liver hepatocellular carcinoma | Liver |
observed |
||
C3H | Liver hepatoma | Liver |
observed |
||
CBA | Liver hepatoma | Liver |
observed |
||
CBA/Birmingham | Liver hepatoma | Liver |
observed |
||
(C57BL/6 x C3H)F1 | Liver hepatoma |
|
Liver |
observed |
|
C57BL/6JNia | Liver neoplasm | Liver |
1.9 - 6 |
||
C57BL/6J | Liver neoplasm | Liver |
0 - 4 |
||
B6;129S4 | Liver neoplasm | Liver |
0 - 16 |
||
B6;129 | Liver neoplasm | Liver |
9 |
||
129S4/SvJae | Liver neoplasm | Liver |
0 - 22.5 |
||
129S4/SvJae | Liver tumor | Liver |
observed |
||
C3H/HeJ | Liver tumor | Liver |
observed |
||
C57BR/cdJ | Liver tumor | Liver |
observed |
||
NMRI | Liver tumor | Liver |
observed |
||
B6;129S4 | Lung - Alveolus - Type II cell adenoma | Lung - Alveolus - Type II cell |
observed |
||
B6;129S4 | Lung - Alveolus - Type II cell carcinoma | Lung - Alveolus - Type II cell |
observed |
||
[not specified]-Prop1df | Lung adenocarcinoma | Lung |
observed |
||
[not specified]-Prop1df/+ | Lung adenocarcinoma | Lung |
observed |
||
C;129P2 | Lung adenocarcinoma | Lung |
observed |
||
CD-1 | Lung adenocarcinoma | Lung |
observed |
||
A/HeN | Lung adenoma | Lung |
observed |
||
(C57BL/6 x C3H/HeN)F1 | Lung adenoma | Lung |
observed |
||
(C57BL/6 x C3H)F1 | Lung adenoma |
|
Lung |
observed |
|
SENCAR | Lung adenoma | Lung |
observed |
||
CD-1 | Lung adenoma | Lung |
observed |
||
A | Lung carcinoma | Lung |
observed |
||
A/HeN | Lung carcinoma | Lung |
observed |
||
B6;129 | Lung carcinoma | Lung |
observed |
||
(C57BL/6 x C3H/HeN)F1 | Lung carcinoma | Lung |
observed |
||
(BALB/cByJ x C57BL/6J)F1 x (C3H/HeJ x DBA/2J)F1 | Lung carcinoma | Lung |
observed |
||
SENCAR | Lung carcinoma | Lung |
observed |
||
C57BL/6JNia | Lung neoplasm | Lung |
0 - 3.8 |
||
C57BL/6J | Lung neoplasm | Lung |
2 - 8 |
||
B6;129S4 | Lung neoplasm | Lung |
0 - 32 |
||
B6;129 | Lung neoplasm | Lung |
17 |
||
129S4/SvJae | Lung neoplasm | Lung |
4 - 62.5 |
||
FVB/NTac | Lung neoplasm | Lung |
observed |
||
(Af x C57BL/6)F1 | Lung neoplasm | Lung |
observed |
||
129S4/SvJae | Lung tumor | Lung |
observed |
||
A/J | Lung tumor | Lung |
observed |
||
A/HeJ | Lung tumor | Lung |
observed |
||
BALB/c | Lung tumor | Lung |
observed |
||
BALB/cStCrlfC3Hf/Nctr | Lung tumor | Lung |
observed |
||
BALB/cAnNBdf | Lung tumor | Lung |
observed |
||
BALB/cAnNIcr | Lung tumor | Lung |
observed |
||
FVB/NTac | Lung tumor | Lung |
observed |
||
FVB/NHsd | Lung tumor | Lung |
observed |
||
CD-1 | Lung tumor | Lung |
observed |
||
NMRI | Lung tumor | Lung |
observed |
||
CD-1 | Mammary gland adenocarcinoma | Mammary gland |
observed |
||
C3H/HeJ | Mammary gland adenocarcinoma - type B |
|
Mammary gland |
observed |
|
C3HeB/FeJ | Mammary gland adenocarcinoma - type B | Mammary gland |
observed |
||
A | Mammary gland carcinoma |
|
Mammary gland |
observed |
|
Af | Mammary gland carcinoma | Mammary gland |
observed |
||
C3H | Mammary gland carcinoma |
|
Mammary gland |
observed |
|
C3Hf | Mammary gland carcinoma | Mammary gland |
observed |
||
GRS | Mammary gland carcinoma | Mammary gland |
observed |
||
FVB/N | Mammary gland hyperplasia | Mammary gland |
observed |
||
FVB/NCr | Mammary gland hyperplasia | Mammary gland |
observed |
||
C3H/HeJ | Mammary gland hyperplasia - alveolar |
|
Mammary gland |
observed |
|
C3HeB/FeJ | Mammary gland hyperplasia - alveolar | Mammary gland |
observed |
||
C57BL/6JNia | Mammary gland neoplasm | Mammary gland |
0 - 2.1 |
||
C57BL/6J | Mammary gland neoplasm | Mammary gland |
0 |
||
B6;129S4 | Mammary gland neoplasm | Mammary gland |
0 |
||
129S4/SvJae | Mammary gland neoplasm | Mammary gland |
0 |
||
BALB/cAnNBdf | Mammary gland tumor | Mammary gland |
observed |
||
C3H/HeJ | Mammary gland tumor |
|
Mammary gland |
observed |
|
C3HeB/FeJ | Mammary gland tumor | Mammary gland |
observed |
||
C3H/HeN | Mammary gland tumor |
|
Mammary gland |
observed |
|
C3H/HeNIcr | Mammary gland tumor | Mammary gland |
observed |
||
C3H/HeNIcrfC57BL | Mammary gland tumor | Mammary gland |
observed |
||
C3H/He | Mammary gland tumor |
|
Mammary gland |
observed |
|
C3H/Hef | Mammary gland tumor | Mammary gland |
observed |
||
DBA | Mammary gland tumor |
|
Mammary gland |
observed |
|
DBAf | Mammary gland tumor | Mammary gland |
observed |
||
DBA/2AnIcr | Mammary gland tumor | Mammary gland |
observed |
||
FVB/NTac | Mammary gland tumor | Mammary gland |
observed |
||
SENCAR | Mammary gland tumor | Mammary gland |
observed |
||
FVB/NTac | Neuroectoderm - Neural crest cell tumor | Subcutis |
observed |
||
BALB/cStCrlfC3Hf/Nctr | Ovary cyst | Ovary |
observed |
||
C57BL/6JfC3Hf/Nctr | Ovary cyst | Ovary |
observed |
||
SAMP | Ovary cyst | Ovary |
observed |
||
C57BL/6JNia | Ovary neoplasm | Ovary |
1.9 |
||
C57BL/6J | Ovary neoplasm | Ovary |
1 |
||
B6;129S4 | Ovary neoplasm | Ovary |
17 |
||
129S4/SvJae | Ovary neoplasm | Ovary |
26.7 |
||
FVB/NTac | Ovary tumor | Ovary |
observed |
||
FVB/NHsd | Ovary tumor | Ovary |
observed |
||
B6;129S4 | Ovary tumor | Ovary |
observed |
||
B6;129S4 | Pancreas - Islet of Langerhans hyperplasia | Pancreas - Islet of Langerhans |
observed |
||
(C57BL/6 x C3H)F1 | Pancreas - Islet of Langerhans hyperplasia |
|
Pancreas - Islet of Langerhans |
observed |
|
C57BL/6JNia | Pancreas neoplasm | Pancreas |
0 |
||
C57BL/6J | Pancreas neoplasm | Pancreas |
0 |
||
B6;129S4 | Pancreas neoplasm | Pancreas |
0 - 4 |
||
129S4/SvJae | Pancreas neoplasm | Pancreas |
0 - 2.1 |
||
FVB/NCr | Pituitary gland - Pars distalis hyperplasia | Pituitary gland - Pars distalis |
observed |
||
C57BL/6JfC3Hf/Nctr | Pituitary gland adenoma | Pituitary gland |
observed |
||
C57BL/6JNia | Pituitary gland adenoma | Pituitary gland |
observed |
||
C57BL/6NNia | Pituitary gland adenoma | Pituitary gland |
observed |
||
FVB/NTac | Pituitary gland adenoma | Pituitary gland |
observed |
||
FVB/NHsd | Pituitary gland adenoma | Pituitary gland |
observed |
||
FVB/NCr | Pituitary gland adenoma | Pituitary gland |
observed |
||
(C57BL/6 x C3H/HeN)F1 | Pituitary gland adenoma | Pituitary gland |
observed |
||
(C57BL/6 x C3H)F1 | Pituitary gland adenoma |
|
Pituitary gland |
observed |
|
(C57BL/6 x C3H)F1 | Pituitary gland adenoma | Pituitary gland |
observed |
||
(C57BL/6 x C3H/HeN)F1 | Pituitary gland carcinoma | Pituitary gland |
observed |
||
(C57BL/6 x C3H)F1 | Pituitary gland carcinoma | Pituitary gland |
observed |
||
C57BL/6JfC3Hf/Nctr | Pituitary gland cyst | Pituitary gland |
observed |
||
C57BL/6JNia | Pituitary gland neoplasm | Pituitary gland |
0 - 25.5 |
||
C57BL/6J | Pituitary gland neoplasm | Pituitary gland |
0 - 7 |
||
B6;129S4 | Pituitary gland neoplasm | Pituitary gland |
0 - 2 |
||
B6;129 | Pituitary gland neoplasm | Pituitary gland |
15 |
||
129S4/SvJae | Pituitary gland neoplasm | Pituitary gland |
0 |
||
FVB/NTac | Pituitary gland prolactinoma | Pituitary gland |
observed |
||
C57BL/6J | Pituitary gland tumor | Pituitary gland |
observed |
||
NMRI | Pituitary gland tumor | Pituitary gland |
observed |
||
FVB/N | Skin - Ear squamous cell carcinoma |
|
Skin - Ear |
observed |
|
CBA/Birmingham | Spleen hyperplasia | Spleen |
observed |
||
(C57BL/6 x C3H/HeN)F1 | Subcutis neoplasm | Subcutis |
observed |
||
129/Sv | Testis teratocarcinoma | Testis |
observed |
||
129/Sv | Testis teratoma | Testis |
observed |
||
AKR | Thymus leukemia | Thymus |
observed |
||
AKR | Thymus lymphoma | Thymus |
observed |
||
AKR/J | Thymus lymphoma | Thymus |
observed |
||
NOD.CB17-Prkdcscid | Thymus lymphoma | Thymus |
observed |
||
B6;129S4 | Thyroid gland - Follicular cell adenoma | Thyroid gland - Follicular cell |
observed |
||
B6;129S4 | Thyroid gland - Follicular cell carcinoma | Thyroid gland - Follicular cell |
observed |
||
(C57BL/6 x C3H)F1 | Thyroid gland cyst |
|
Thyroid gland |
observed |
|
C57BL/6JNia | Thyroid gland neoplasm | Thyroid gland |
0 |
||
C57BL/6J | Thyroid gland neoplasm | Thyroid gland |
0 |
||
B6;129S4 | Thyroid gland neoplasm | Thyroid gland |
2 - 8 |
||
129S4/SvJae | Thyroid gland neoplasm | Thyroid gland |
0 - 4.2 |
||
(C57BL/6 x C3H)F1 | Uterus - Endometrium cyst |
|
Uterus - Endometrium |
observed |
|
(BALB/cByJ x C57BL/6J)F1 x (C3H/HeJ x DBA/2J)F1 | Uterus - Endometrium hyperplasia | Uterus - Endometrium |
observed |
||
C57BL/6JfC3Hf/Nctr | Uterus - Endometrium hyperplasia - cystic | Uterus - Endometrium |
observed |
||
B6;129S4 | Uterus - Endometrium tumor | Uterus - Endometrium |
observed |
||
C3H/HeJ | Uterus hyperplasia - glandular |
|
Uterus |
observed |
|
C3HeB/FeJ | Uterus hyperplasia - glandular | Uterus |
observed |
||
C57BL/6JNia | Uterus neoplasm | Uterus |
3.8 |
||
C57BL/6J | Uterus neoplasm | Uterus |
4 |
||
B6;129S4 | Uterus neoplasm | Uterus |
8 |
||
129S4/SvJae | Uterus neoplasm | Uterus |
20.8 |
||
BALB/cStCrlfC3Hf/Nctr | Uterus polyp | Uterus |
observed |
||
C57BL/6JfC3Hf/Nctr | (Unspecified organ) angiosarcoma | (Unspecified organ) |
observed |
||
C57BL/6JNia | (Unspecified organ) neoplasm | (Unspecified organ) |
57 - 71 |
||
C57BL/6J | (Unspecified organ) neoplasm | (Unspecified organ) |
35 - 50 |
||
B6;129S4 | (Unspecified organ) neoplasm | (Unspecified organ) |
25 - 60 |
||
B6;129 | (Unspecified organ) neoplasm | (Unspecified organ) |
49 - 80 |
||
129S4/SvJae | (Unspecified organ) neoplasm | (Unspecified organ) |
0 - 35 |
||
C57L | (Unspecified organ) reticulum cell neoplasm | (Unspecified organ) |
observed |
||
BALB/cStCrlfC3Hf/Nctr | (Unspecified organ) reticulum cell sarcoma | (Unspecified organ) |
observed |
||
BALB/cAnNBdf | (Unspecified organ) reticulum cell sarcoma | (Unspecified organ) |
observed |
||
SJL/J | (Unspecified organ) reticulum cell sarcoma | (Unspecified organ) |
observed |
||
NMRI | (Unspecified organ) tumor | (Unspecified organ) |
observed |